Novartis UK has been recognized for its “people-first” human resources (HR) practices by being officially certified as a 2019 Top Employer by the Top Employers Institute, the sixth consecutive year the company has been granted this status. Sandoz UK, a division of the Novartis Group, has also been certified as a 2019 Top Employer. The annual, international Top Employer award recognizes market-leading employers that provide exceptional employee conditions. Contributing to Novartis UK’s success this year was the launch of three new wellbeing initiatives: • the Ensemble program, which supports Novartis associates in the UK whose lives have been affected by cancer, whether they are facing cancer as an individual, caregiver or as a manager; • a mental health action plan, put in place across Novartis UK to break the stigma about mental health in the workplace; • the Energized for Life program, which encourages all Novartis employees to realize their full potential and be their “best self every day and everywhere”. The program concentrates on a new cultural aspiration to be inspired, curious and “unbossed”. Erica Cassin, HR Director at Novartis UK, commented: “This year we have placed huge focus on our employee wellbeing offering through the launch of UK-specific support hubs for associates affected by mental health challenges and cancer. I am extremely proud that these important initiatives have contributed to our Top Employer success, and that they help to ensure Novartis remains an employer of choice.” www.top-employers.com
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.